Literature DB >> 2183806

Measurement of functional status, quality of life, and utility in rheumatoid arthritis.

M J Bell1, C Bombardier, P Tugwell.   

Abstract

In 40 years of development in the area of quality of life, the goal of applicability to the individual patient has not been accomplished. During the 1980s, we strived to improve the applicability of these instruments by refining disease-specific measures and developing patient-specific measures so that the sensitivity of these tools to clinically important change could be increased and comparative indices across conditions could be established. Finding the balance between brevity, reliability, and comprehensiveness will improve practicality. The reliability of serial measurements using the various instruments in individual patients and in small groups of patients needs to be established. In the absence of a gold standard, validity will continue to be derived from testing new measures against accepted clinical measures. The ideal tool for use in clinical practice has not yet been developed. At this time, the clinician may choose among the many reliable and valid questionnaires assessing functional status, health status, and utility, according to his or her purpose. The information gathered from these instruments may help identify patients' problems, set treatment priorities, direct interventions, monitor the longitudinal course of disease, and assist in program evaluation and policy planning.

Entities:  

Mesh:

Year:  1990        PMID: 2183806     DOI: 10.1002/art.1780330420

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

Review 1.  Juvenile rheumatoid arthritis--assessment.

Authors:  T B Graham; E H Giannini
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Quality of life in Indian patients with rheumatoid arthritis.

Authors:  Gurdesh S Bedi; Nikhil Gupta; Rohini Handa; Hemraj Pal; R M Pandey
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

Review 3.  Assessment of quality of life in rheumatoid arthritis: methods and implications.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

Review 4.  The costs of rheumatoid arthritis.

Authors:  S H Allaire; M J Prashker; R F Meenan
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

5.  Values for function in rheumatoid arthritis: patients, professionals, and public.

Authors:  S Hewlett; A P Smith; J R Kirwan
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

Review 6.  Technology assessment in healthcare: a means for pursuing the goals of biomedical engineering.

Authors:  C S Goodman
Journal:  Med Biol Eng Comput       Date:  1993-01       Impact factor: 2.602

7.  Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ).

Authors:  S Hewlett; A P Smith; J R Kirwan
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 8.  Quality of life 3. Rheumatoid arthritis.

Authors:  P L Van Riel; W G Van Lankveld
Journal:  Pharm World Sci       Date:  1993-06-18

Review 9.  Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

10.  Measure of function in rheumatoid arthritis: individualised or classical scales?

Authors:  R Seror; F Tubach; G Baron; F Guillemin; P Ravaud
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.